Vermont Academic Detailing Program
THE VERMONT ACADEMIC DETAILING PROGRAM is a university-based prescriber education and support program. The Program is offered by the University of Vermont’s Office of Primary Care with funding from public and private sources, including the State of Vermont. There is no pharmaceutical company sponsorship associated with the Vermont Academic Detailing Program nor do the program faculty have any ties to the pharmaceutical industry. The faculty objectively review clinical topics, covering the latest evidence for lifestyle changes and generic medications in addition to the latest in medication releases. This information is shared with health care teams across Vermont.
The goal of the Vermont Academic Detailing Program is to promote high quality, evidence-based, patient-centered, and cost-effective treatment decisions by health care professionals.
COVID-19 and Academic Detailing
We invite you to join our academic detailers for virtual academic detailing sessions and in person sessions (scheduled on a case-by-case basis, contingent upon current COVID-19 protocols). We will continue to offer virtual sessions on Zoom, which qualify for continuing education credits and are specifically designed to be delivered between one clinician and one academic detailer. This keeps the conversation focused and efficient.
* Indicates session is a qualifying CME activity related to the topic of safe and effective prescribing of controlled substances required by the Vermont Board of Medical Practice.
"Primary Prevention of Cardiovascular Disease – Management of Lipids"
This session highlights practical aspects of managing patients with dyslipidemia with medication therapies and lifestyle interventions. The session focuses on the available evidence-base for statin and non-statin use in primary prevention and estimation of 10-year risk of ASCVD by calculating an ASCVD risk score.
"Primary Prevention of
Cardiovascular Disease – Management of Blood Pressure"
This session highlights
practical aspects of managing patients with hypertension with medication
therapies and lifestyle interventions. The session focuses on the available
evidence-base for antihypertensive medication use in primary prevention and
estimation of 10-year risk of ASCVD by calculating an ASCVD risk score.
"Management of Chronic Obstructive Pulmonary Disease (COPD)"
This session highlights the practical aspects of managing patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD) in primary care, with a focus on the available evidence‐base. This session includes information about medication therapies and a description of the various inhaler devices. The session also includes resources for patient education.
This session highlights the practical aspects of managing patients prescribed or using cannabinoids in primary care, with a focus on the available evidence-base. This session includes information about prescription, medical marijuana, and over-the-counter cannabinoid products (e.g. CBD) and discusses the risks and benefits of various options.
"Management of Fibromyalgia" *
This topic includes reviewing the diagnosis of fibromyalgia, evaluating the evidence for non-pharmacologic management options, and discussing the pharmacologic approaches to management.
"Advanced Management of Opioids" *
This session highlights the practical aspects of managing patients prescribed opioids in primary care. This session includes reviewing the rules for both prescribing and querying the Vermont Prescription Monitoring System (VPMS). This session includes information about how to safely initiate and discontinue opioids in primary care.
NEWLY UPDATED "Management of Type 2 Diabetes"
This session highlights the new, non-insulin medications for managing patients with type 2 diabetes in primary care, with a focus on the available evidence‐base related to cardiac and other outcomes. This session also includes information about nutrition and lifestyle, insulin safety, and recommendations from the American Diabetes Association guidelines.
"Oral Health and Fluoride Varnish in Primary Care Medical Practices"
This session offers an evidence-based pediatric (infants, toddlers, and preschool children, ages 6 months to the 6th birthday) oral health review to assist primary care medical practices with integrating the following as a standard of care: assess the oral health of young children; apply fluoride varnish to help prevent tooth decay; educate parents and caregivers about pediatric oral health; and make dental referrals.
Scheduling and Other Important Information
These FREE programs offer prescribers CME credit to physicians, pharmacists, and nurses and can be scheduled as small group or one-on-one sessions in your office for any of these topics; we also offer "live" sessions virtually on Zoom. Sign up for a session online at: https://www.signupgenius.com/go/vtad or by contacting the Vermont Academic Detailing Program Coordinator to schedule a session.
For a printable version of Vermont Academic Detailing information please click here.
To achieve our goals, we rely on the guidance and broad opinions of multiple stakeholders. We have formalized these stakeholders as Vermont Academic Detailing Program Advisors. The role of the Program Advisor is to provide opinions and practical advice regarding the approach, direction, and operation of the Vermont Academic Detailing Program.
For more information about academic detailing beyond Vermont, please visit the National Resource Center for Academic Detailing (NaRCAD)